One prominent example is the somatic c-kit D816V mutation which is used as minimally invasive secondary diagnostic criterion to confirm systemic mastocytosis, since >80% of patients with systemic mastocytosis are tested positive for this single nucleotide polymorphism (SNP) (131–133). This evidence concerns the gene KIT and systemic mastocytosis.